Skip to main content
SpringerLink
Log in

Fernmetastasen besser vorhersagen

  • Literatur kompakt
  • Published:
gynäkologie + geburtshilfe Aims and scope

Viele Ärzte verwenden das Rezidivrisiko als Basis für Entscheidungen über die adjuvante Therapie bei Patienten mit Mammakarzinom. Nun wurde untersucht, ob ein Gentest bzw. ein davon abgeleiteter Score genauere Informationen über die Prognose als klinische Parameter liefert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Gnant M et al. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. Ann Oncol. 2014; 25(2): 339–45

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Judith Neumaier & Wolfram Malter

Authors
  1. Judith Neumaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfram Malter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neumaier, J., Malter, W. Fernmetastasen besser vorhersagen. gynäkologie + geburtshilfe 19, 15–16 (2014). https://doi.org/10.1007/s15013-014-0422-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15013-014-0422-z

Search

Navigation